Two of the most talked-about medications in the weight loss industry are tirzepatide and semaglutide
Some clinicians frame the target differently, using goal body weight rather than current body weight
The markets upliftment in the region is primarily attributed to strong direct-to-consumer commercialization, favorable reimbursement expansions, and the prevalence of high diabetes and obesity
Your provider reviews your individual treatment plan, current dose, and any underlying conditions that might affect whether a timing adjustment is appropriate for you
Clinical trials do not show harmful changes in core body temperature
Semaglutide (the active ingredient in brand-name drugs Ozempic, Rybelsus, and Wegovy) is a GLP-1 receptor agonist, antidiabetic, and weight loss drug